Authors


Charles Bernick, MD

Latest:

Role of Fluid Biomarkers and GFAP in Neurodegeneration: Charles Bernick, MD

The neurologist at Cleveland Clinic provided perspective on the reasons to study individuals exposed to repetitive head impacts and the lessons learned about monitoring glial fibrillary acidic protein over time. [WATCH TIME: 4 minutes]


Stephen Peroutka, MD

Latest:

PPD/TFS Fostering Global Awareness in Rare Disorders

Rare Disease Day raises awareness for rare disorders, highlighting challenges, improving detection, and fostering collaboration for treatment advancements.


Donovan Lott, PT, PhD, CSCS

Latest:

Maximizing Exercise as Movement Medicine for Neuromuscular Diseases: Donovan Lott, PT, PhD, CSCS

The research associate professor in the department of physical therapy at the University of Florida talked about physical therapy inventions for neuromuscular diseases at the 2023 MDA conference. [WATCH TIME: 4 minutes]


Olga Thon, MD

Latest:

New Horizons in Multiple Sclerosis

Experts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.



Jacqueline Glascock, PhD

Latest:

2022 SMA Research & Clinical Care Meeting: What to Expect

Mary Schroth, MD, and Jacqueline Glascock, PhD, of Cure SMA, share their perspectives on the upcoming annual meeting.


Jeannette R. Mahoney, PhD

Latest:

Digital Health Tool Offers Innovative Quantitative Fall Assessment Solution for Older Adults

Falls cost the US more than $50 billion annually, but platforms like CatchU, a transformative digital health tool, provide quantitative fall assessment that might significantly enhance the current standard of care for predicting falls.


Alistair Mackett, MD

Latest:

The Future of Parkinson Disease Treatment With Innovative Wearable Devices: Alistair Mackett, MD

The movement disorder specialist at Cambridge University Hospitals NHS Foundation Trust discussed the rise of wearable technology for managing Parkinson disease to potentially empower patients and monitor the disease at early stages. [WATCH TIME: 4 minutes]


Anne H. Cross, MD

Latest:

Shifting to a Collaborative Approach to Conquer Challenges in Progressive MS: Anne H. Cross, MD

The professor of neurology at Washington University School of Medicine discussed the growing sense of hope among patients with progressive multiple sclerosis as providers gain an understanding in treating this form of the disease. [WATCH TIME: 3 minutes]


Kari Rosbeck

Latest:

TSC Alliance’s Growth Has Led to Improved Lives and Progress Toward a Cure

In light of Tuberous Sclerosis Complex (TSC) Awareness Month throughout May, Kari Rosbeck, president and CEO, TSC Alliance, highlights what has been done to advance TSC research and how the organization is improving the diagnosis journey, access to care, and support for families.


Claude Steriade, MD, CM

Latest:

Epilepsy Awareness and First Aid for Seizures in 2024: Claude Steriade, MD, CM

The epileptologist at NYU Langone Health and associate professor of neurology at NYU Grossman School of Medicine talked about the ongoing need to improve public awareness and education on seizure first aid. [WATCH TIME: 3 minutes]


Konstantin Karmazin, MD

Latest:

Future Plans, Goals for Prime PD: Konstantin Karmazin, MD

The chief medical officer of Prime PD, a new digital wellness studio for patients with Parkinson disease, detailed future initiatives for the platform. [WATCH TIME: 4 minutes]


Juan Bulacio, MD

Latest:

The Evolutionary Arch of Stereoelectroencephalography in the United States

SEEG has transformed the surgical investigation of refractory epilepsy, enabling clinicians to map complex seizure networks with precision, leading to more targeted treatment options for patients.


Christopher Elder, MD

Latest:

Recommendations for Treating Epilepsy in the Clinical Space: Christopher Elder, MD

The clinical assistant professor of neurology in the Comprehensive Epilepsy Center at NYU Langone Health gives recommendations for clinical care on prescribed antiseizure medication and RNA therapy. [WATCH TIME: 5 minutes]


George Grossberg, MD

Latest:

Assessing Potential Treatment Options for Agitation in Older Adults With Alzheimer Disease: George Grossberg, MD

The director of Geriatric Psychiatry at the St Louis University School of Medicine talked about BXCL501 as a potential treatment for acute agitation in patients with Alzheimer disease and how it compares with brexpiprazole, the first approved therapy. [WATCH TIME: 4 minutes]


Junxin Li, PhD, MS, RN, FAAN

Latest:

Clinical Utility of Neurofilament Light in Older Adults With Sleep Disorders: Junxin Li, PhD, MS, RN, FAAN

The associate professor at Johns Hopkins School of Nursing provided insight on a presentation at SLEEP 2023, and whether neurofilament light should be more considered when assessing elderly patients with sleep disorders. [WATCH TIME: 5 minutes]


Gwen Zeigler, DO

Latest:

Health Care Avoidance and Neurological Needs in Transgender and Gender-Diverse Patients

Transgender and gender-diverse patients have unique neurological considerations, but often, neurologists are unaware of the needs that are specific to this community.


Cheryl D. Bushnell, MD, MHS, FAHA

Latest:

Enhancing Stroke Prevention Guidelines Through Diverse Evidence and Inclusive Care: Cheryl D. Bushnell, MD, MHS, FAHA

The professor of neurology at Wake Forest University School of Medicine discussed the importance of expanding the diversity of clinical trial populations, considering the impact of social determinants of health, and ensuring accessibility for high-risk underserved groups. [WATCH TIME: 4 minutes]


David Vossler, MD

Latest:

David Vossler, MD: Treating Generalized Tonic-Clonic Seizures

The Medical Director of The Neuroscience Institute at UW Medicine Valley Medical Center discussed the landscape of therapy for tonic-clonic seizures and how lacosamide might fit into the paradigm.


Sílvia Porta, PhD

Latest:

Promising Therapeutic Developments for TDP-Related Pathologies: Sílvia Porta, PhD

The research assistant professor, pathology and laboratory medicine, University of Pennsylvania, talked about the ongoing research in her lab on understanding the mechanisms and consequences of TDP-43 aggregation in Alzheimer Disease. [WATCH TIME: 4 minutes]


Lisanne Dommershuijsen, MSc

Latest:

Takeaways From MDS 2021: Lisanne Dommershuijsen, MSc

Following her presentation at MDS 2021, the PhD candidate in epidemiology at Erasmus University Medical Center discussed highlights from this year’s virtual congress. [WATCH TIME: 2 minutes]


Ricardo Alonso MD, MSc

Latest:

A Neurological Perspective on Lessons from the COVID-19 Pandemic in NMOSD: Lorna Galleguillos, MD; Ricardo Alonso MD, MSc

The neuroimmunologist at Clínica Alemana de Santiago and head of the University Center for Multiple Sclerosis at Ramos Mejía Hospital discussed Latin American efforts to understand neuromyelitis optica spectrum disorder during the COVID-19 pandemic. [WATCH TIME: 5 minutes]


Russell Lonser, MD

Latest:

Recent Progress in Advancing Gene Therapy for Parkinson Disease: Russell Lonser, MD

The director for the Gene Therapy Institute at The Ohio State University talked about the latest developments in gene therapy for patients with Parkinson disease. [WATCH TIME: 4 minutes]


Patricia C. Dugan, MD

Latest:

Narrowing the Treatment Gap and Raising Awareness of Surgical Options for Epilepsy: Patricia C. Dugan, MD

The associate professor of neurology at NYU Grossman School of Medicine talked about the need for increased awareness in the medical community to address the underutilization of surgical interventions for refractory focal epilepsy. [WATCH TIME: 4 minutes]


Andrea Synowiec, DO

Latest:

The Interconnected Reality of Neurologic and Psychiatric Disorders in Migraine: Andrea S. Synowiec, DO, FAAN

The system vice chair for the department of neurology at Allegheny Health Network talked about the growing evidence emphasizing the need for a more holistic approach to patient care in migraine. [WATCH TIME: 4 minutes]



Abby Rogers, DMSc, PA-C, MPAS

Latest:

High-Efficacy Disease-Modifying Therapies for Multiple Sclerosis

Jason Freeman, MD, MBA, and Abby Rogers, DMSc, PA-C, MPAS, discuss a study presented at ACTRIMS 2023 on high-efficacy disease-modifying therapies for treatment-naïve patients with multiple sclerosis. Sponsored by Novartis.


Alvin Wang, DO, BC-EMS

Latest:

The Benefits of Mobile Stroke Units: Alvin Wang, DO, BC-EMS

The chief of emergency medical services at Jefferson Health spoke about the operation of the Jefferson mobile stroke unit in the field, and the impact that the onset of the COVID-19 pandemic had on launching the program. [WATCH TIME: 3 minutes]


Prashant A. Natteru, MBBS, MD

Latest:

Unravel the Mysteries of Multiple Sclerosis Mimics

Despite the diagnosis of MS improving, misdiagnosis remains a challenge, pointing to the need for proper differential diagnosis and mimic identification.


Melinda Magyari, MD

Latest:

Unpacking the Controversy of Hormone Therapy in Multiple Sclerosis: Melinda Magyari, MD

The neurologist in the Danish Multiple Sclerosis Center at Copenhagen University Hospital discussed the debate surrounding the use of hormone therapy in multiple sclerosis treatment, highlighting the need for more clinical evidence to support its use. [WATCH TIME: 5 minutes]

© 2024 MJH Life Sciences

All rights reserved.